Oncotarget
GFH009: A Potent and Highly Selective CDK9 Inhibitor for the Treatment of Hematologic Malignancies
December 27, 2023
BUFFALO, NY- December 27, 2023 A new #research
Oncotarget is a primarily oncology-focused, peer-…
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast